Belgium· BE-AMP-SAM136184-00
Betagan 0.5 %
A betaxolol product containing levobunolol hydrochloride, registered in Belgium by Allergan Pharmaceuticals Ireland. The same ATC class is registered in 11 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Betaxolol is registered in 11 of 19 countries.
Countries holding a registration under ATC S01ED02 (betaxolol), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 7 of them publish a price we can compare per daily dose
Betaxolol · ATC S01ED02
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Levobunolol Hydrochloride
- Manufacturer
- Allergan Pharmaceuticals Ireland
- Country
- Belgium (BE)
- ATC code
- S01ED02
- ATC class
- Betaxolol
- Defined daily dose
- 0.2 ml, AT
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 2
- be_apb0600205
- be_apb0730333
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
95 interactions on record for betaxolol.
Graded by severity as the source publishes them — 8 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Betaxolol · interactions on record
95 records
- 8 severe
- 85 moderate
- 2 minor
Most severe, free to view
- TheophyllinC01EB28severe
- CeritinibL01ED02severe
- CeritinibL01XE28severe
- SiponimodL04AA42severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Betaxolol in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomBetagan 0.5% eye dropsLexon (UK) Ltd
- FinlandBetaganAllergan Limited
- FranceBETAGAN 0,5 % , collyre en solution en récipient unidoseABBVIE
- GermanyVistagan Liquifilm O.K.Abbvie Deutschland Gmbh & Co. Kg
- IrelandBetagan 0.5% w/v Unit Dose Eye Drops, SolutionAbbVie Limited
- ItalyVISTAGAN*collirio 60 flaconcini monodose 0,4 ml 5 mg/mlABBVIE Srl
- United StatesLevobunolol HydrochlorideBausch & Lomb Incorporated
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- France · Betagan
- Italy · Vistagan
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/3a26237b-feab-4f46-acc8-3591220a4708 GET /v1/drugs/3a26237b-feab-4f46-acc8-3591220a4708?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Eye drops, solution",
"source": "afmps",
"status": "REVOKED",
"name_en": "Betagan 0.5 %",
"name_fr": "Betagan 0.5 %",
"name_nl": "Betagan 0.5 %",
"amp_code": "SAM136184-00",
"strengths": [
"5.0000",
"5.0000"
],
"pack_count": 1,
"substances": [
"Levobunolol Hydrochloride"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Betaxolol",
"authorisation_numbers": [
"BE136184"
]
}See everything about betaxolol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.